Lupin Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: LUPIN BSE: 500257

₹2030.20

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #10 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Lupin Limited (this stock)	92,827	13.3	23.8%	2.5%	—	92	75	44

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹93,293 Cr

EV / EBITDA

9.7x

EV / Sales

4.45x

Market cap / Sales

4.43x

Earnings yield

7.49%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 7,274 Cr, up 26.2% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 2,715 Cr, up 27.6% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	7,172	3,610	2,715	₹59.3700
March 31, 2026	5,235	2,602	2,164	₹47.3500
Dec. 31, 2025	4,501	868	717	₹15.7100
Sept. 30, 2025	4,068	1,636	1,357	₹29.7200
June 30, 2025	5,709	2,588	2,128	₹46.6000
March 31, 2025	4,486	1,553	1,291	₹28.3000
Dec. 31, 2024	4,208	1,217	985	₹21.5800
Sept. 30, 2024	4,106	984	808	₹17.7100
June 30, 2024	4,168	1,083	889	₹19.5100
March 31, 2024	3,396	428	384	₹8.4300
Dec. 31, 2023	4,116	1,084	916	₹20.1400
Sept. 30, 2023	3,659	696	549	₹12.0600
June 30, 2023	3,496	577	477	₹10.4800

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	7,274	5,323	4,601	4,138	5,763	4,534	4,263	4,139	4,206	3,427	4,139	3,685	3,523
Operating revenue	7,172	5,235	4,501	4,068	5,709	4,486	4,208	4,106	4,168	3,396	4,116	3,659	3,496
Other income	102	89	100	70	54	49	55	33	38	31	23	26	28
Operating expenses	3,439	2,953	2,885	2,893	2,979	2,740	2,797	2,991	2,968	2,696	2,898	2,824	2,791
Operating profit	3,733	2,282	1,617	1,176	2,730	1,746	1,411	1,115	1,200	700	1,217	835	705
Operating profit margin	52.1%	43.6%	35.9%	28.9%	47.8%	38.9%	33.5%	27.1%	28.8%	20.6%	29.6%	22.8%	20.2%
Depreciation	190	177	179	175	177	208	153	146	141	290	145	149	140
Interest	36	39	36	28	19	34	20	18	14	13	11	15	16
Exceptional items, gain / (loss)	—	448	-634	593	—	—	-77	—	—	—	—	—	—
Profit before tax	3,610	2,602	868	1,636	2,588	1,553	1,217	984	1,083	428	1,084	696	577
Tax	895	439	150	278	460	262	232	176	194	44	168	147	100
Net profit	2,715	2,164	717	1,357	2,128	1,291	985	808	889	384	916	549	477
EPS	59.37	47.35	15.71	29.72	46.60	28.30	21.58	17.71	19.51	8.43	20.14	12.06	10.48
Net profit (TTM)	6,953	6,367	5,494	5,761	5,212	3,973	3,066	2,997	2,738	2,326	2,061	1,185	785
EPS (TTM)	152.15	139.38	120.33	126.20	114.19	87.10	67.23	65.79	60.14	51.11	45.30	26.05	17.26

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	19,513	7,694	6,367
March 31, 2025	16,968	4,837	3,973
March 31, 2024	14,666	2,785	2,326
March 31, 2023	11,259	527	425

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	20.4%	12.1%	19,825^†	17,142^†	14,774^†	11,353^†	11,923^†	11,204^†	11,508^†	11,819^†	10,268^†	12,948^†
Operating revenue	20.1%	12.0%	19,513	16,968	14,666	11,259	11,772^†	11,056^†	11,026^†	11,356^†	10,088^†	12,725^†
Other income	—	—	313^†	175^†	108^†	94^†	151^†	148^†	482^†	462^†	179^†	223^†
Operating expenses	—	—	11,709^†	11,496^†	11,209^†	10,179^†	11,496^†	9,031^†	9,125^†	8,675^†	—	8,367^†
Operating profit	93.3%	31.0%	7,804^†	5,472^†	3,458^†	1,080^†	275^†	2,026^†	1,901^†	2,682^†	—	4,358^†
Operating profit margin	—	—	40.0%^†	32.2%^†	23.6%^†	9.6%^†	2.3%^†	18.3%^†	17.2%^†	23.6%^†	—	34.2%^†
Depreciation	—	—	707^†	648^†	725^†	548^†	514^†	503^†	519^†	426^†	—	366^†
Interest	—	—	121^†	84^†	56^†	98^†	73^†	41^†	53^†	35^†	33^†	22^†
Exceptional items, gain / (loss)	—	—	407^†	-77^†	0^†	0^†	0^†	0^†	-759^†	-340^†	0^†	0^†
Profit before tax	144.4%	36.4%	7,694	4,837	2,785	527	-162^†	1,630^†	1,052^†	2,342^†	1,794^†	4,179^†
Tax	—	—	1,328^†	864^†	459^†	102^†	27^†	371^†	325^†	804^†	449^†	1,038^†
Net profit	146.5%	38.3%	6,367	3,973	2,326	425	-189^†	1,259^†	728^†	1,539^†	1,345^†	3,141^†
EPS	146.0%	38.1%	139.38^†	87.10^†	51.11^†	9.36^†	-4.16^†	27.78^†	16.08^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	40.0%^†	32.2%^†	23.6%^†	9.6%^†	2.3%^†	18.3%^†	17.2%^†	23.6%^†	—	34.2%^†
EBIT margin	40.1%^†	29.0%^†	19.4%^†	5.6%^†	-0.7%^†	15.1%^†	10.0%^†	20.9%^†	18.1%^†	33.0%^†
PBT margin	39.4%	28.5%	19.0%	4.7%	-1.4%^†	14.7%^†	9.5%^†	20.6%^†	17.8%^†	32.8%^†
Net margin	32.6%	23.4%	15.9%	3.8%	-1.6%^†	11.4%^†	6.6%^†	13.6%^†	13.3%^†	24.7%^†
Interest coverage	64.34x^†	58.24x^†	50.42x^†	6.35x^†	-1.20x^†	41.12x^†	21.01x^†	67.04x^†	54.97x^†	193.41x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	3.23x	3.68x	—	—	—	—	—	—	—	—
Quick ratio	2.53x	2.68x	—	—	—	—	—	—	—	—
Debt to equity	0.02x	0.01x	—	—	—	—	—	—	—	—
Return on equity	21.1%	16.4%	—	—	—	—	—	—	—	—
Return on assets	17.6%	14.0%	—	—	—	—	—	—	—	—
Return on capital employed	25.0%^†	19.5%^†	—	—	—	—	—	—	—	—
Asset turnover	0.54x	0.60x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	5,540	-5,649	-121	717	4,823
March 31, 2025	2,445	-1,766	-460	1,294	1,150
March 31, 2024	2,505	-1,600	-867	699	1,806
March 31, 2023	1,785	-1,260	-498	575	1,209
March 31, 2022	252	-473	102	597	-345

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	36,103	30,134	30,042	577	0	15,595	4,832	112	3,169	3,351
March 31, 2025	28,432	24,278	24,187	0	226	11,895	3,233	342	3,446	3,227
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.